Infections in asplenic patients

Clinical Microbiology and Infection

Volumn 1, Issue 4, 1996, Pages 266-272

  Jenks, Peter J ^a   Jones, Eleri ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005695378     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Morris DH, Bullock FD. The importance of the spleen in resistance to infection. Ann Surg 1919; 70: 513-21.
2. O'Donnell FJ. The value of splenectomy in Banti's disease. Br Med J 1929; I: 854.
3. King H, Schumacker HB. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg 1952; 136: 239-42.
4. Whitaker AN. Infection and the spleen: association between hyposplenism, pneumococcal sepsis and disseminated intravascular coagulopathy. Med J Aust 1969; 1: 1213-19.
5. Martin LW. Autologous splenic transplantation. Ann Surg 1994; 219: 223-4.
6. Holdsworth RJ. Regeneration of the spleen and splenic autotransplantation. Br J Surg 1991; 78: 270-8.
7. Rosse WR The spleen as a filter. N Engl J Med 1987; 317: 704-6.
8. Davies KA, Erlendsson K, Beynon HL, et al. Splenic uptake of immune complexes in man is complement-dependent. J Immunol 1993; 151: 3866-73.
9. Hosea SW, Brown EJ, Hamburger M, Frank MM. Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med 1981; 304: 245-50.
10. Hazelwood M, Kumararatne DS. The spleen? Who needs it anyway? Clin Exp Immunol 1992; 89: 327-9.
11. Klaus GG, Kunkle A. The role of germinal centres in the generation of immunological memory. In: Klaus GG and Kunkle A, eds. Microenvironment in haemopoietic and lymphoid differentiation. London: Pitman Medical, 1981: 125-280.
12. Lockwood CM. Immunological functions of the spleen. Clin Haematol 1983; 12: 449-65.
13. Timens W, Lemans R. Splenic autotransplantation and the immune system. Ann Surg 1992; 215: 256-60.
14. Mosier DE, Subbarao B. Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunol Today 1982; 3: 217-22.
15. Kamaratne DS, Bazin H, MacLennan IC. Marginal zones: the major B cell compartment in rat spleens. Eur J Immunol 1981; 11: 858-64.
16. Amlat PL, Grennan D, Humphrey JH. Splenic dependence of the antibody response to thymic independent (TI-2) antigens. Eur J Immunol 1985; 15: 508-12.
17. Timens W, Boes A, Rozeboom-Ultenvijk T, Poppema S. Immaturity of the human splenic marginal zone in infancy. J Immunol 1989; 143: 3200-6.
18. Rynnel-Dagoo B, Freijd A, Hammarstrom L, Oxelius V, Persson MA, Smith CI. Pneumococcal antibodies of different immunoglobulin subclasses in normal and IgG subclass deficient individuals of various ages. Acta Otolaryngol (Stockh) 1986; 101: 146-51.
19. Gray D, Chassoux D, MacLennan IC, Bazin H. Selective depression of thymus independent anti-DNP antibody response induced by adult but not neonatal splenectomy. Clin Exp Immunol 1985; 60: 78-86.
20. Eichner ER. Splenic function: normal, too much, and too little. Am J Med 1979; 66: 311-20.
21. Van Wyck DB. Overwhelming postsplenectomy infection (OPSI): the clinical syndrome. Lymphology 1983; 16: 107-14.
22. Cullingford GI, Watkins DN, Watts AJ, Mallon DF. Severe late post-splenectomy infection. Br J Surg 1991; 78: 716-21.
23. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991; 78: 1031-8.
24. Pimpl W, Dapunt O, Kaindl H, Thalhamer J. Incidence of septic and thromboembolic-related deaths after splenectomy in adults. Br J Surg 1989; 76: 517-21.
25. O'Neal BJ, McDonald JC. The risk of sepsis of the asplenic adult. Ann Surg 1981; 194: 775-8.
26. Ellison EC, Fabri PJ. Complications of splenectomy: aetiology, prevalence and management. Surg Clin North Am 1983; 63: 1313-30.
27. Hicklin H, Verghese A, Alvarez S. Dysgonic fermenter 2 septicaemia. Rev Infect Dis 1987; 9: 884-90.
28. Morgan MS, Cruikshank JG. Prevention of postsplenectomy sepsis. Lancet 1993; 341: 700-1.
29. Wyler DJ, Oster CN, Quinn TC. The role of the spleen in malaria infection. In Role of the spleen in the immunity of parasitic diseases. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Basel: Schwabe & Co., 1983: 183-204.
30. Boone KE, Watters AK. The incidence of malaria after splenectomy in Papua New Guinea. Br Med J 1995; 311: 1273.
31. Boycott G. Boycott: The autobiography. London: Corgi Books, 1993.
32. Rossner R, Zarrabi MH, Benach JL, Hubicht GS. Babesiosis in splenectomised adults: review of 22 reported cases. Am J Med 1984; 76: 696-701.
33. Dammin GJ, Spielman A, Benach JL, Piesman J. The rising incidence of clinical Babesia microti infection. Hum Pathol 1981; 12: 398-400.
34. Konradsen HB, Henrichsen J. Pneumococcal infection in splenectomised children are preventable. Acta Paediatr Scand (Stockh) 1991; 80: 423-7.
35. Shapiro ED, Berg A, Aubren R, et al. The protective efficacy of polyclonal pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325: 1453-60.
36. Bolan G, Broome CV, Fracklam RR, Plikaytis BD, Fraser DW, Schlech WF. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med 1986; 104: 1-6.
37. Caplan ES, Boltansky H, Snyder MJ, et al. Response of traumatised splenectomised patients to immediate vaccination with polyvalent pneumococcal vaccine. J Trauma 1983; 23: 801-5.
38. Shildt RA, Boyd JF, McCraete JD, et al. Antibody response to pneumococcal vaccine in patients with solid tumours and lymphomas. Med Paediatr Oncol 1983; 11: 305-9.
39. Department of Health. Immunisation against infectious diseases. London: HMSO, 1992.
40. Graham RC. Long term management after splenectomy: has been amended [letter]. Br Med J 1994; 308: 133.
41. Obaro S, Henderson DC, Monteil M. Long term management after splenectomy: monitor antibody levels after vaccination [letter]. Br Med J 1994; 308: 338-9.
42. Ambrosino DM, Lee MY, Chen D, Shamberger RC. Response to Haemophilus influenzae type b conjugate vaccine in children undergoing splenectomy. J Pediatr Surg 1992; 27: 1045-7.
43. Ruben FL, Hawkins WA, Zeigler Z, et al. Antibody response to meningococcal polysaccharide vaccine in adults without a spleen. Am J Med 1984; 76: 115-21.
44. Sumaya CV, Harbison RW, Bretton HA. Pneumococcal vaccine failures. Am J Dis Child 1981; 135: 155-8.
45. Gaston MH, Venton JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anaemia. N Engl J Med 1986; 314: 1593-9.
46. Murdock IA, Dos Anjos R. Continued need for penicillin prophylaxis after splenectomy. Arch Dis Child 1990; 65: 1268-9.
47. Read RC, Finch RG. Prophylaxis after splenectomy. J Antimicrob Chemother 1994; 33: 4-6.
48. Department of Health. Asplenic patients and immunisation. CMO's Update 1994; 1: 3.
49. Chadwick PR, Keaney MG, Jones RA. Meningitis due to penicillin-resistant Streptococcus pneumoniae occurring in a patient on long term ampicillin prophylaxis. J Infect 1993; 27: 277-9.
50. Zarrabi MH, Rosner FJ. Rarity of failure of penicillin prophylaxis to prevent postsplenectomy sepsis. Arch Intern Med 1986; 146: 1207-9.
51. Deodhar HA, Marshall RJ, Barnes JN. Increased risk of sepsis after splenectomy. Br Med J 1993; 307: 1408-9.
52. White KS, Covington D, Churchill P, Maxwell JG, Norman KS, Clarey TV. Patient awareness of health precautions after splenectomy. Am J Infect Control 1991; 19: 36-41.